European Medicines Agency (EMA) strengthens PRIME (Priority Medicines) with new features
The EMA is introducing new features to its Priority Medicines Initiative (PRIME) to support the development of medicines in areas of unmet medical need and speed up the approval process in the European Union. The new features include: Establishing a roadmap and product development tracker for each PRIME development. Providing expedited scientific advice specific to […]
